510(k) K071745

BAYLIS PAIN MANAGEMENT SINGLE-USE PROBE by Baylis Medical Co., Inc. — Product Code GXI

K071745 is an FDA 510(k) premarket notification submitted by Baylis Medical Co., Inc. for the device "BAYLIS PAIN MANAGEMENT SINGLE-USE PROBE". The FDA issued a decision of Substantially Equivalent on July 19, 2007. The device falls under product code GXI (Probe, Radiofrequency Lesion), a Class II device regulated under 21 CFR 882.4725. Baylis Medical Co., Inc. has at least 10 other 510(k) clearances on record.